Pharmascience Inc. is recalling 13 lots of prescription and over-the-counter ranitidine drugs (150 mg tablets) after tests found NDMA, a nitrosamine impurity, at below but close to the accepted level.
GRAND RAPIDS, Mich. — Meijer joins Walmart and CVS in halting the sale of over-the-counter acid reducer medications such as Zantac that may contain a "probable human carcinogen." Drugs with the active ...
Dr. Reddy's initiates voluntary recall of ranitidine due to microbial contamination. The Indian pharmaceutical company Dr. Reddy’s Laboratories has initiated a voluntary recall of five lots of ...
Pharmaceutical giant Sanofi announced Friday it will voluntarily recall heartburn drug Zantac in the U.S. and Canada because of concerns over potential cancer risks. The French drugmaker said it ...
Hosted on MSN
After 5 Years, Acid-Reducer Is Back on the Market
The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled from shelves over concerns that it could break down into a carcinogen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results